A changing picture
Cancer is not static. Circulating tumour DNA can, in appropriate settings, offer a way to observe molecular change during treatment.
Research continues into how best to use this information, and practice varies by cancer type and clinical situation.
Interpreting with care
Assay sensitivity, tumour burden and biological variability all affect results.
Findings are interpreted alongside imaging, clinical assessment and pathology rather than in isolation.